Drug Type CAR-T |
Synonyms- |
Mechanism CXCR2 antagonists(C-X-C motif chemokine receptor 2 antagonists), EGFRvIII antagonists(Epidermal growth factor receptor variant III antagonists), IL18R1 inhibitors(Interleukin 18 receptor inhibitors) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | - | 05 Apr 2023 |